InspireMD, Inc. Warrants
NSPRW
NSPRW was delisted on the 7th of July, 2021.
1 hedge funds and large institutions have $0 invested in InspireMD, Inc. Warrants in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
100% less capital invested
Capital invested by funds: $1K → $0 (-$1K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$49 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| – | -$49 | -6,655 | -11% |
|
NSPRW Hedge Fund Activity: Q3 2019 in Review
1 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Warrants (NSPRW) for Q3 2019, worth a combined $0 — down 100% from $1K a quarter earlier.
Fund positioning in NSPRW was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $49.
- 1 institutional investor held InspireMD, Inc. Warrants (NSPRW) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $0 of InspireMD, Inc. Warrants stock for Q3 2019, down 100% quarter-over-quarter.
- 0 funds opened new InspireMD, Inc. Warrants positions in Q3 2019 and 0 closed out.
- The largest InspireMD, Inc. Warrants seller in Q3 2019 was UBS Group, an estimated $49 sold.
Based on aggregated 13F filings for Q3 2019.